If you are applying to ID Fellowship this summer, @UCSF_ID provides outstanding clinical training, strong research and med ed mentorship, and a commitment to diversity in an incredibly beautiful city. Please check us out! infectiousdiseases.ucsf.edu/…
We are hiring! The @ucsfhealth ID Division is hiring faculty for 2 roles: (1) academic clinicians interested in general ID & (2) Director of General ID Programs. Details & application in link. Reach out to @BSchwartzinSF with questions. aprecruit.ucsf.edu/JPF05192
If you are applying to ID Fellowship this summer, @UCSF_ID provides outstanding clinical training, strong research and med ed mentorship, and a commitment to diversity and inclusion in an incredibly beautiful city. Please check us out! infectiousdiseases.ucsf.edu/…
Applying to ID Fellowship this cycle? @UCSF_ID offers outstanding clinical training, strong research & med ed mentorship, & commitment to diversity and inclusion in one of the most beautiful cities in the US. We hope you check us out!
infectiousdiseases.ucsf.edu/…
1/N **New @WHO guidelines** are published for control & elimination of #schistosomiasis! This is a historic day- first new WHO guidelines in 10 years with big policy changes that ⬆️ access to meds! Was a great privilege to serve as lead guidelines writer.who.int/publications/i/item/…
An honor for me to get to teach on a mystery DOM Grand Rounds with @Bob_Wachter presenting and Lisa Winston as the discussant! Thanks to @UCSFIMChiefs@fangdisun who put it all together. Great case and good learning, listen to us here:
youtube.com/watch?v=C0ojeYm7…
Consult❓:“can I safely discharge a patient with a substance use disorder home with a PICC?”
The inimitable @jabarocas and I have some thoughts: a [ahem, very long] 🧵 on our Curbside Consult in @NEJMEvidence today.
1/15
Pearl from @UCSF_ID#grandrounds —>
Unsure abt rifabutin instead of rifampin to treat latent or active tuberculosis in a patient on methadone?
Janice Louie 💪🏾 director of @SF_DPH TB Clinic says SF routinely uses rifabutin with similar TB tx outcomes.
Long-awaited results from ANCHOR study are out, showing screening & early treatment of anal dysplasia (HSIL) reduces risk of #analcancer in people with #HIV. @UCSF@NIHanchorstudy.org/
There are lots of great resources for learning about COVID out there, but to get all of the latest in one place, in one day, delivered by folks leading one of the nation’s most effective responses, consider @UCSF_HIVIDGM’s CME session!